Pharmacy Enforcement

BE CAUTIOUS WHEN BUYING MEDICINES ONLINE

Date: 19 September 2019 - 2:38pm

For further information, kindly visit to https://www.pharmacy.gov.my/v2/en/website/waspada-belian-ubat-online

PN. NORMAWATI BINTI MOHAMED NOOR,

SEKSYEN KAWAL SELIA IKLAN UBAT,

CAWANGAN KAWALAN IKLAN,

BAHAGIAN PENGUATKUASAAN FARMASI, KKM

normawati_mn@moh.gov.my

03-78413239

Kempen Tolak Ubat Tidak Sah (TOBaTS)

Date: 14 June 2024 - 9:35am

 

 

 

 

 

 

 

 

The “TOLAK UBAT TIDAK SAH” campaign, officially abbreviated as “TOBaTS,” is a new initiative by the Pharmacy Enforcement Division , Ministry of Health (MOH) to combat the issue of illegal supply and sale of medicines in Malaysia.

What can I do if I have enquiry or would like to get explanation on the approved format by MAB?

Applicants can reach out officers in the secretariat through multiple ways such as phone call (03-7841 3200), email (liu@moh.gov.my), letter or face-to-face meet up if they have enquiry on the approved format. Reasons/ justifications for cancellation of statements or words in the approved advertisement formats or rejection of advertisements will be explained by officers to you. 

Is self-regulation of pharmaceutical products advertisement feasible to be carried out in Malaysia?

Self-regulation is not permissible under Medicines (Advertisement and Sale) Act 1956 and MABR 1976. Subject to R5(1) MABR 1976, all advertisement must be approved by MAB prior to publication. Pharmacy Enforcement Division is in the process of revising Medicines (Advertisement and Sale) Act 1956 and MABR 1976. Stakeholders’ involvement and input can be submitted to the Pharmacy Enforcement Division, MOH.

What is the way forward for MAB in the application of approval process?

Pharmacy Services Program is currently developing an online system called MyPharmaC which enables online application. This system will encompass online payment and online application of approval, which will facilitate the process of application and approval of advertisement. 

What is the difference between the new guidelines and old guidelines?

The main difference in the new GP is the insertion of examples to better explain the context of the GP. Besides, the new GP also consolidates infographic of decision tree, guideline to fill up the application form, application form for new application and amendment, format of celebrity endorsement and customer testimony and the appeal notice to Minister of Ministry of Health Malaysia. 

There are also changes in the provisions within the new guidelines, such as press release of NCE products is now allowed to be published more than one time; supplement products are allowed to be offered as gift for the purchase of the same product; and mandatory statement “This is a medicine/ supplement/ traditional product” has been removed from advertisement format has also been stated in the new guidelines.
 

Are advertisements related to disease awareness program are allowed?

Disease awareness programmes or health education campaign aiming to create awareness on health and diseases without promoting health products is permissible as there are no violations under S4B Medicines (Advertisement & Sale) Act 1956. The organizers should always ensure that no advertisements related to medicinal products are displayed or exhibited during the program.

Pages